InvestorsHub Logo
icon url

BearGator56

07/18/24 2:08 PM

#177215 RE: nathanial #177181

I'm only barely above my cost basis, but that's mostly because of continuing to buy after RS with lower share cost. We might've "made money" after the RS, but it's nowhere near the potential of what the ROI was without RS and FDA human approval.